Información*
| Nombre | EMMANUEL DE LA MORA JIMENEZ |
|---|---|
| Área | MEDICINA Y CIENCIAS DE LA SALUD |
| Campo | INVESTIGACIÓN MÉDICA |
| Disciplina | ONCOLOGÍA, QUIMIOTERAPIA, CIRUGÍA ONCOLOGÍA |
| Especialidad | ONCOLOGIA, QUIMIOTERAPIA, CIRUGIA ONCOLOGIA |
| CVU | 812425 |
| Institución | |
|---|---|
| Dependencia | INSTITUTO JALISCIENCE DE CANCEROLOGIA |
| Entidad | JALISCO |
| Nivel | C |
| Vigencia | Inicio: 01/01/2026 |
| Fin: 31/12/2029 |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Últimas publicaciones Scopus
- 2026
- Cognitive Impairment Associated with Chemotherapy: Neuroimmunological Interactions, Gut–Brain Axis, and Therapeutic Approaches Brain Sciences · Vol. 16 Review
- 2025
- MicroRNAs in the Mitochondria–Telomere Axis: Novel Insights into Cancer Development and Potential Therapeutic Targets Genes · Vol. 16 Review
- 2024
- Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor-Resistant, EGFR-Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer Journal of Clinical Oncology · Vol. 42 Article
- Pembrolizumab With or Without Lenvatinib for First-Line Metastatic NSCLC With Programmed Cell Death-Ligand 1 Tumor Proportion Score of at least 1% (LEAP-007): A Randomized, Double-Blind, Phase 3 Trial Journal of Thoracic Oncology · Vol. 19 Article
- Strain Elastography Fat-to-Lesion Index Is Associated with Mammography BI-RADS Grading, Biopsy, and Molecular Phenotype in Breast Cancer Biosensors · Vol. 14 Article
